Advanced Pet Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics is organized by CME Science and will be held during May 04 - 05, 2018 at Wynn Las Vegas, Las Vegas, Nevada, United States of America.
The target audience for this medical event is practicing radiologists, nuclear medicine physicians and radiologic nurses, physician assistants, technologists, residents, fellows and others who are interested in the clinical applications of PET and PET/CT. This CME Conference has been approved for a maximum of 16 AMA PRA Category 1 Credits.
Conference Objectives are :
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT.
• Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice.
• Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging.
• Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT.
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
Speakers: Johannes Czernin MD, Andrew Quon MD, Don C. Yoo MD
Additional details will be posted as soon as they are available.
|Registration Type||End Date||Price|
|Practicing Physician/Industry - Conference Fee||03 May,2018||USD 1295.00|
|Military/Retired/Scientist/VA - Conference Fee||03 May,2018||USD 1195.00|
|Resident/Fellow/Technologist/PA/Nurse - Conference Fee||03 May,2018||USD 995.00|